Anzeige
Mehr »
Login
Freitag, 27.09.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Insider-Alarm: Warum Insider Millionen von Aktien dieses Goldwerts kaufen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 867141 | ISIN: US6284641098 | Ticker-Symbol: MJF
Frankfurt
26.09.24
08:00 Uhr
12,300 Euro
+0,100
+0,82 %
1-Jahres-Chart
MYERS INDUSTRIES INC Chart 1 Jahr
5-Tage-Chart
MYERS INDUSTRIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
12,00012,80026.09.
ACCESSWIRE
208 Leser
Artikel bewerten:
(1)

Myers Industries Turned to John Galt Solutions to Transform and Advance Supply Chain Planning Processes

Atlas Planning Platform Standardized Processes Across Business Units for Global Plastics and Metal Manufacturer

AUSTIN, TX / ACCESSWIRE / September 25, 2024 / John Galt Solutions, a global leader in automating supply chain planning to empower businesses to make better decisions faster, today announced that its market-leading Atlas Planning Platform was successfully implemented at Myers Industries Inc., to help the company standardize processes and support growth across its separate business units.

Myers, a leading manufacturer of a wide range of plastic and metal products and a distributor for the tire, wheel, and under-vehicle service industry, faced challenges as the business expanded, both organically and through acquisitions. As a result, Myers required an advanced supply chain planning solution that could unify fragmented processes and systems into a centralized platform, establishing best practices to support its continued growth.

Myers selected John Galt Solutions' Atlas Planning Platform for its superior ability to improve visibility across the end-to-end supply chain. With Atlas, Myers can pull data from different external and internal data sources into a single platform, optimizing and improving processes across the business.

Since the implementation, Myers has benefited from a uniform view across its supply chain. The platform's data-driven dashboards provide real-time insights into key performance indicators (KPIs) across the network and help guide the supply chain team to accelerate decisions that best align with company objectives. The standardization of processes has helped the company align its operations with its financial goals, moving Myers toward a fully integrated business plan.

"The Atlas Planning Platform has provided our business with the visibility and integration we required to support our growth," said Jeff Baker, Senior Vice President of Shared Services at Myers. "We now have a single, unified view of our supply chain, which has greatly improved our ability to forecast demand and align operations with our financial objectives. The dashboards have become instrumental in driving consistent metrics and providing greater visibility into performance across the organization. Atlas empowers our team to work more effectively toward an integrated business plan, ensuring that every part of the company is moving in the same direction."

Looking ahead, Myers is preparing to enter the next phase of its collaboration with John Galt Solutions, which will focus on the implementation of what-if scenario planning, leveraging the Artificial Intelligence (AI) capabilities in the Atlas Planning Platform. This will allow Myers to conduct simulations that stress-test its supply chain under various conditions, delivering deeper insights into how the supply chain reacts under uncertainty and helping the company make more informed decisions.

"We're excited to continue supporting Myers Industries as they explore new opportunities to further advance their supply chain planning and enhance performance," said Matt Hoffman, Vice President of Product and Industry Solutions at John Galt Solutions. "With the power of AI and what-if scenario planning, Myers will be better equipped to plan, manage, and respond to the complexities of their diverse markets and industries, ensuring their supply chain stays agile and resilient."

About Myers Industries

Myers Industries Inc. (NYSE:MYE), based in Akron, Ohio, is a manufacturer of sustainable plastic and metal products for industrial, agricultural, automotive, commercial, and consumer markets. The company is also the largest distributor of tools, equipment and supplies for the tire, wheel, and under-vehicle service industry in the United States. Visit myersindustries.com to learn more.

About John Galt Solutions

More than ever, companies must be able to sense and respond to the dynamics of complex global supply chain performance, seize new opportunities, reduce?costs,?and drive profitability. John Galt Solutions' Atlas Planning Platform is a comprehensive end-to-end supply chain planning software solution with advanced analytics and machine learning to automate planning, break down business silos and deliver greater visibility. A SaaS-based platform, Atlas transforms S&OP processes;?demand,?inventory,?and replenishment;?supply and inventory optimization;?manufacturing planning and scheduling;?financial budget and sales forecasting. We partner closely with companies such as MARS, Continental Tire, Milwaukee Tool, Deschutes Brewery, Netgear, and American Red Cross to empower planners to make better and faster decisions with greater confidence. To learn how John Galt Solutions can help you improve supply chain performance, visit?johngalt.com.??

Contact Information

John Galt
Public Relations Manager
connect@johngalt.com
312-701-9026

SOURCE: John Galt Solutions

.

View the original press release on newswire.com.

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.